{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:52:57Z","timestamp":1785552777910,"version":"3.56.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The precise mechanisms by which alpha-lipoic acid (LA) alleviates nab-paclitaxel (nab-PTX)-induced peripheral neuropathy have yet to be fully elucidated. The objective of this study was to investigate the mechanisms underlying the neuroprotective effects of LA in mitigating nab-PTX-induced peripheral neuropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We established a rat model of nab-PTX-induced peripheral neuropathy to evaluate the efficacy of LA. To systematically elucidate the mechanisms by which LA alleviates nab-PTX-induced peripheral neuropathy, we utilized an integrated approach that combined network toxicology and network pharmacology. Subsequently, molecular docking analysis was performed to assess the binding affinity of the LA to the target proteins involved in the key signaling pathway. Furthermore, experimental validation was conducted to confirm the role of the key signaling pathway in the neuroprotective mechanism of LA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LA was demonstrated to effectively alleviate nab-PTX-induced peripheral neuropathy. The network analysis indicated that LA ameliorated nab-PTX-induced peripheral neuropathy primarily through the AGE-RAGE signaling pathway in diabetic complications, IL-17 signaling pathway, fluid shear stress and atherosclerosis, NOD-like receptor signaling pathway, and pathways of neurodegeneration - multiple diseases. The molecular docking indicated a potential impact of LA on the IL-17 signaling pathway. Further experiment validation revealed that nab-PTX activated the IL-17 signaling pathway, whereas LA could mitigate nab-PTX-induced peripheral neuropathy by inhibiting this pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>By integrating network toxicology analysis, network pharmacology analysis, and experimental validation, this study provides a clearer understanding of the mechanisms by which LA ameliorates nab-PTX-induced peripheral neuropathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1674709","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:14:39Z","timestamp":1764306879000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Alpha-lipoic acid ameliorates nab-paclitaxel-induced peripheral neuropathy by inhibiting IL-17 signaling pathway"],"prefix":"10.3389","volume":"16","author":[{"given":"Hong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taomin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2217\/17435889.2.4.415","article-title":"Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel","volume":"2","author":"Stinchcombe","year":"2007","journal-title":"Nanomed (Lond)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12282-022-01425-2","article-title":"Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04)","volume":"30","author":"Futamura","year":"2023","journal-title":"Breast Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1159\/000535994","article-title":"Efficacy of nanoparticle albumin-bound paclitaxel (nab-PTX) monotherapy can be improved after treatment with immune checkpoint inhibitor in patients with non-small cell lung cancer: long-term follow-up and updated analysis of two previous prospective clinical studies","volume":"102","author":"Nakashima","year":"2024","journal-title":"Oncology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005430","article-title":"Results of a phase II study on the use of neoadjuvant chemotherapy (FOLFIRINOX or GEM\/nab-PTX) for borderline-resectable pancreatic cancer (NUPAT-01)","volume":"275","author":"Yamaguchi","year":"2022","journal-title":"Ann Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e77890","DOI":"10.1136\/bmj-2023-077890","article-title":"Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial","volume":"385","author":"Liu","year":"2024","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1038\/s41467-024-46444-z","article-title":"Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial","volume":"15","author":"Wu","year":"2024","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.critrevonc.2019.04.021","article-title":"Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis","volume":"139","author":"Guo","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00542-2","article-title":"Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial","volume":"17","author":"Untch","year":"2016","journal-title":"Lancet Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-024-01551-z","article-title":"A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer","volume":"31","author":"Kida","year":"2024","journal-title":"Breast Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00280-015-2833-5","article-title":"Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration","volume":"76","author":"Chen","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1486686","article-title":"Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy","volume":"15","author":"Girdenyt\u0117","year":"2024","journal-title":"Front Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012967.pub2","article-title":"Alpha-lipoic acid for diabetic peripheral neuropathy","volume":"1","author":"Baicus","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/nu15163634","article-title":"Effects of oral alpha-lipoic acid treatment on diabetic polyneuropathy: A meta-analysis and systematic review","volume":"15","author":"Hsieh","year":"2023","journal-title":"Nutrients"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-023-01346-8","article-title":"The therapeutic potential of antioxidants in chemotherapy-induced peripheral neuropathy: evidence from preclinical and clinical studies","volume":"20","author":"Zhou","year":"2023","journal-title":"Neurotherapeutics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2008.08.013","article-title":"Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy","volume":"214","author":"Melli","year":"2008","journal-title":"Exp Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3142732","article-title":"Alphalipoic acid prevents oxidative stress and peripheral neuropathy in nab-paclitaxel-treated rats through the nrf2 signalling pathway","volume":"2019","author":"Sun","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2024.153847","article-title":"Analysis of environmental pollutant Bisphenol F elicited prostate injury targets and underlying mechanisms through network toxicology, molecular docking, and multi-level bioinformatics data integration","volume":"506","author":"Huang","year":"2024","journal-title":"Toxicology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula","volume":"309","author":"Zhao","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"B20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0304-3959(94)90023-X","article-title":"Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain","volume":"59","author":"Yoon","year":"1994","journal-title":"Pain (Amsterdam)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the drugBank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae883","article-title":"Comparative Toxicogenomics Database\u2019s 20th anniversary: update 2025","volume":"53","author":"Davis","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.62407","article-title":"Online Mendelian Inheritance in Man (OMIM \u00ae): VictorMcKusick \u2018s magnum opus","volume":"185","author":"Hamosh","year":"2021","journal-title":"Am J Med Genet A"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1113","article-title":"The STRING database in 2025: protein networks with directionality of regulation","volume":"53","author":"Szklarczyk","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/plants11182381","article-title":"Effects of salt stress on the morphology, growth and physiological parameters of juglansmicrocarpa L","volume":"11","author":"Ji","year":"2022","journal-title":"Seedlings Plants (Basel)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2020.07.012","article-title":"Phase 1 dose-escalation study of triweekly nab-paclitaxel combined with S-1 for HER2-negative metastatic breast cancer","volume":"20","author":"Morimoto","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ph17081010","article-title":"Navigating preclinical models and medications for peripheral neuropathy: A review","volume":"17","author":"Jali","year":"2024","journal-title":"Pharm (Basel)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s43450-023-00370-1","article-title":"Molecular and therapeutic insights of alpha-lipoic acid as a potential molecule for disease prevention","volume":"33","author":"Tripathi","year":"2023","journal-title":"Rev Bras Farmacogn"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim Et Biophys Acta (Bba) - Gen Subj"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.08.003","article-title":"Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice","volume":"12","author":"Kim","year":"2011","journal-title":"J Pain"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.999407","article-title":"Interleukin-17 as a potential therapeutic target for chronic pain","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2025.138569","article-title":"Biomass fuel induces neuroinflammation and neurodegeneration via the astrocyte-microglia IL-17A\/IL-17RA pathway","volume":"494","author":"Liang","year":"2025","journal-title":"J Hazard Mater"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/19768354.2025.2510994","article-title":"The role of interleukin-17 in neurological disorders","volume":"29","author":"Park","year":"2025","journal-title":"Anim Cells Syst (Seoul)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2024.111168","article-title":"NaHS alleviates neuropathic pain in mice by inhibiting IL-17-mediated dopamine (DA) neuron necroptosis in the VTA","volume":"220","author":"Wang","year":"2025","journal-title":"Brain Res Bull"},{"key":"B39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3892\/mmr.2016.6018","article-title":"IL-17 contributed to the neuropathic pain following peripheral nerve injury by promoting astrocyte proliferation and secretion of proinflammatory cytokines","volume":"15","author":"Sun","year":"2017","journal-title":"Mol Med Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-27","article-title":"TNF-\u03b1 and neuropathic pain - a review","volume":"7","author":"Leung","year":"2010","journal-title":"J Neuroinflamm"},{"key":"B41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","article-title":"Regulation and function of the human HSP90AA1 gene","volume":"570","author":"Zuehlke","year":"2015","journal-title":"Gene"},{"key":"B42","doi-asserted-by":"publisher","first-page":"E2189-98","DOI":"10.1073\/pnas.1525096113","article-title":"Paclitaxel-induced epithelial damage and ectopic MMP-13 expression promotes neurotoxicity in zebrafish","volume":"113","author":"Lisse","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113121","article-title":"Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems","volume":"324","author":"Staff","year":"2020","journal-title":"Exp Neurol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1055\/a-2047-3896","article-title":"AGE RAGE pathways: cardiovascular disease and oxidative stress","volume":"73","author":"Sharma","year":"2023","journal-title":"Drug Res (Stuttgart)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121142","article-title":"NAG-1\/GDF15 inhibits diabetic nephropathy via inhibiting AGE\/RAGE-mediated inflammation signaling pathways in C57BL\/6 mice and HK-2 cells","volume":"311","author":"Chen","year":"2022","journal-title":"Life Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656908","article-title":"The role of tumor necrosis factor in manipulating the immunological response of tumor microenvironment","volume":"12","author":"Laha","year":"2021","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.01805.x","article-title":"Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells","volume":"86","author":"Milani","year":"2003","journal-title":"J Neurochem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1674709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:14:40Z","timestamp":1764306880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1674709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2025.1674709"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1674709","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"article-number":"1674709"}}